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cells. The results indicate that DON not only inhibits de novo purine biosynthesis but that it also prevents hexosamine synthesis and, ultimately, cell-wall synthesis in E. coli.
The role of 6-diazo-5-oxo-L-norleucine (DON) as a glutamine antagonist has been clarified by numerous studies with both whole cells and isolated enzyme preparations (see Brockman, 1963) . Particular attention has been given to the inhibitory role DON plays in de novo purine biosynthesis; this appears to be a major area of DON activity, because the addition of l)urine bases or ribonucleosides is moderately effective in p)reventing DON inhibition in bacteria. LGlutamine effectively prevents DON inhibition of a cell-free enzyme system (Chakraborty and Hurlbert, 1961; Hurlbert, 1962) but has not proven to be effective in preventing DON inhibition in whole cells. The structure of DON is: N5'N 0 1 1 1 1
C-C-(CH2)2-CH-C O OH H NH2
MIartin and Moo-Penn (1963) demonstrated an extended lag when ethionine-resistant Escherichia coli were grown in a glucose-salts medium in the absence of ethionine. They further denmonstrated that this lag could be prevented by including ethionine or the natural metabolite, methionine, in the growth medium. A Mutant selection. The minimal inhibitory concentration of DON for E. coli was 1.0 ,ug/ml in spread plates and 0.1 ,g/ml in broth when 107 viable cells per milliliter were tested.
When 107 viable sensitive cells of E. coli were spread on minimal agar containing 10 ,ug/ml of DON, resistance in a single-step experiment occurred with a frequency of 4.5 X 10-5 per viable cell. The loss of resistance when resistant cells were cultured in broth in the absence of DON for 24 hr, washed, and plated on minimal agar containing 10 jug/ml of DON was 8 X 10-3 per viable cell. Resistance was maintained, with this frequency of loss, even after cells were cultured in broth without DON through four subcultures.
Altered morphology. Filament formation was observed in cultures during the transition from DON sensitivity to full resistance. The changes in morphology are shown in Fig. 1 . It is significant that these changes occurred only during the development of resistance; the morphology of the fully resistant cell appears identical to that of the sensitive cell. When sensitive cells were treated with DON, numerous spheroplast-like forms could be observed by phase microscopy in the presence of 20% sucrose.
Growth characteristics of resistant cells. Resistant cells grown in the absence of DON had an extended lag some 5 hr longer than that of the sensitive strain (Fig. 2 ). This extended lag was observed only when the resistant inoculum was prepared from cells cultured in the presence of drug. Inocula prepared from resistant cells grown in the absence of DON, although still fully resistant, did not show a significant lag.
Prevention of the resistant cell lag phase. When minimal broth was supplemented with DON (1.0 Ag/ml), the growth curve of the resistant culture approximated that of the drug-sensitive culture (Fig. 3 ). Since morphological observations had indicated that DON might interfere with cell-wall synthesis, several basic units of cell-wall structure were tested to determine whether their addition would prevent the lag in growth. In addition to DON, D-glucosamine or inosine individually decreased the apparent lag phase of resistant cells, but, when both were present in the minimal broth, the growth curve of resistant cells was almost identical to that of DON-sensitive cells (Fig. 3) . L-Lysine, D-alanine, DLdiaminopimelic acid, L-glutamine, uridine diphosphate, and N-acetyl-D-glucosamine were without significant effect even when tested at a concentration of 300 Ag/ml. Adenine (100 Ag/ml) and guanine (50 Ag/ml) were tested and were somewhat less effective than inosine. These purine bases are readily converted to adenosine and guanosine, respectively, in E. coli when supplied exogenously (Britten et al., 1963) .
Viability studies on resistant cells during extended lag period. Viability studies were conducted on resistant cells during the extended lag phase. The results (Fig. 4) show that a decrease in the number of viable cells occurs during the first 2 hr, and is followed by recovery and the subsequent development of the culture. The loss in viability was prevented by the addition of DON (1 to 10 ,ug/ml) to the broth culture. Inosine or glucosamine reduced the viability loss to some extent, but, when both metabolites were present, viable counts did not decrease and normal growth ensued. When platings were made on nutrient agar for these test conditions, viability counts were lower than counts on minimal agar. When resistant isolates were picked from minimal plates, cultured in broth without DON, and tested for viability in aerated broth without additions as previously described, no decrease in the number of viable cells occurred. If the same colonies were cultured in broth with DON and these cells used as inocula in unsupplemented broth, a loss of about one-half the initial population occurred.
Reversal of DON-inhibited cells. The effect of inosine and glucosamine as preventative agents of DON inhibition of sensitive cells was next investigated (Fig. 5) . When sensitive cells were inoculated into broth containing DON (10 ,ug/ml) and inosine (100 ,ug/ml), an initial phase of growth occurred for 3.5 hr, followed by rapid clearing of the culture. Secondary growth was observed between 6 and 8 hr, again followed by a loss in turbidity. In broth containing glucosamine and DON, no growth was observed through When the inhibitor was added to sensitive cells in mid-log phase of growth, an initial loss of turbidity of the culture was observed followed by some growth and then growth cessation (Fig.  6) . The same effect was observed with cells grown in the presence of inosine. In broth containing glucosamine, further growth was prevented, but a decrease in turbidity was not observed. Growth of cultures containing both inosine and glucosamine was not inhibited by the addition of DON at mid-log phase, although there appeared to be a change in the growth rate. The addition of DON at mid-log phase to resistant cells growing in the absence of inhibitor (following an extended lag) resulted in only a very slight alteration in the rate of growth.
Effect of L-glutamine. L-Glutamine (100 jug/ml) (Tomisek and Reid, 1962 Pathways leading to the synthesis of both glucosamine and inosinic acid utilize amination reactions involving the transfer of the amide nitrogen from glutamine to an acceptor molecule. DON has been shown to be a strong inhibitor of the glutamine transamidase reactions converting fructose-6-phosphate to glucosamine-6-phosphate (Ghosh et al., 1960) , and the binding of DON to transamidases appears to be irreversible (Hurlbert and Kammen, 1960) .
Glucosamine can be directly phosphorylated by adenosine triphosphate to form glucosamine-6-phosphate, thus by-passing the DON-sensitive transamidase reaction in the biosynthesis of glucosamine-6-phosphate (Kornfeld et al., 1964) , a precursor of the basic cell-wall constituent Nacetyl-glucosamine. The direct phosphorylation of N-acetyl-glucosamine has been demonstratedl for E. coli (Ansensio, 1960) 
